Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 5/20 | 0.33 |
| ▸ | MMP3 | P08254 | 5/20 | 0.33 |
| ▸ | BIRC2 | Q13490 | 5/20 | 0.33 |
| ▸ | MMP1 | P03956 | 3/20 | 0.33 |
| ▸ | MMP7 | P09237 | 1/20 | 0.33 |
| ▸ | Q9HBH1 | 1/20 | 0.33 | |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28479377 | 0.89 | CPB2 (0.39) | CA1CA2KMT2AMMP2MMP3 | |
| SCHEMBL475633 | 0.86 | FOLH1 (0.44) | CA2KMT2AMMP2MMP3MMP1 | |
| SCHEMBL767600 | 0.84 | FOLH1 (0.43) | CA2KMT2AMMP2MMP3MMP1 | |
| SCHEMBL28996826 | 0.82 | MMP2 (0.36) | KMT2AMMP2MMP3BIRC2MMP1 | |
| SCHEMBL21066650 | 0.81 | FOLH1 (0.43) | CA2KMT2AMMP2MMP3MMP1 | |
| SCHEMBL17363691 | 0.81 | MMP2 (0.42) | MMP2MMP3BIRC2MMP1MMP7 | |
| SCHEMBL21066700 | 0.80 | FOLH1 (0.42) | CA2KMT2AMMP2MMP3MMP1 | |
| SCHEMBL21066696 | 0.80 | FOLH1 (0.42) | CA2KMT2AMMP2MMP3MMP1 | |
| SCHEMBL8747473 | 0.79 | CA1 (0.38) | CA1CA2KMT2AZDHHC7 | |
| SCHEMBL1176862 | 0.79 | CA2 (0.69) | CA1CA2MMP2MMP3BIRC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7709221-B2 | Biosensor with inorganic-organic hybrid polymer coating | FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2010-05-04 | — | — | US | disclosed |
| US-20070202270-A1 | Method And Apparatus For Coating A Substrate Using Dielectric Barrier Discharge | VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK (VITO) (BE) | 2007-08-30 | — | — | US | disclosed |
| US-20070161069-A1 | Biosensor and its use | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2007-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161069-A1 | Biosensor and its use | MGAM, FBP1, UGDH | CA1 1424/4885CA2 343/4885KMT2A 3125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.